Dong Kim - NexturnBioscience Non-Executive Independent Director
| 089140 Stock | KRW 3,395 100.00 3.03% |
Director
Kim Dong Gi was NonExecutive Independent Director of Nesturn Co., Ltd since March 24, 2011. Kim used to be Chief Executive Officer of KOREA FANUC CORPORATION. Kim holds a Bachelor degree from Korea University. since 2011.
| Age | 61 |
| Tenure | 13 years |
| Phone | 82 3 1288 2088 |
| Web | https://www.nexturn.co.kr |
Dong Kim Latest Insider Activity
Tracking and analyzing the buying and selling activities of Dong Kim against NexturnBioscience stock is an integral part of due diligence when investing in NexturnBioscience. Dong Kim insider activity provides valuable insight into whether NexturnBioscience is net buyers or sellers over its current business cycle. Note, NexturnBioscience insiders must abide by specific rules, including filing SEC forms every time they buy or sell NexturnBioscience'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Dong Kim over two months ago Disposition of 2500 shares by Dong Kim of UroGen Pharma subject to Rule 16b-3 |
NexturnBioscience Management Efficiency
The company has return on total asset (ROA) of 0.0793 % which means that it generated a profit of $0.0793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 2.0662 %, meaning that it generated $2.0662 on every $100 dollars invested by stockholders. NexturnBioscience's management efficiency ratios could be used to measure how well NexturnBioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | DIRECTOR Age | ||
| Choi Hwanjin | Camus Engineering Construction | N/A | |
Management Performance
| Return On Equity | 2.07 | |||
| Return On Asset | 0.0793 |
NexturnBioscience Leadership Team
Elected by the shareholders, the NexturnBioscience's board of directors comprises two types of representatives: NexturnBioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NexturnBioscience. The board's role is to monitor NexturnBioscience's management team and ensure that shareholders' interests are well served. NexturnBioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NexturnBioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dong Kim, Non-Executive Independent Director | ||
| Jae Lee, Internal Auditor | ||
| Wung Moon, Director | ||
| Yeong Jung, Chief Executive Officer, Director | ||
| YoungHwa Jung, Chief Officer |
NexturnBioscience Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NexturnBioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.07 | |||
| Return On Asset | 0.0793 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 170.8 B | |||
| Shares Outstanding | 10.43 M | |||
| Shares Owned By Insiders | 24.07 % | |||
| Shares Owned By Institutions | 0.27 % | |||
| Price To Earning | 78.14 X | |||
| Price To Sales | 0.68 X |
Pair Trading with NexturnBioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NexturnBioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NexturnBioscience will appreciate offsetting losses from the drop in the long position's value.Moving against NexturnBioscience Stock
| 0.66 | 039610 | HS Valve | PairCorr |
| 0.6 | 277810 | Rainbow Robotics | PairCorr |
| 0.53 | 005385 | Hyundai Motor | PairCorr |
| 0.52 | 005387 | Hyundai Motor | PairCorr |
| 0.48 | 005935 | Samsung Electronics | PairCorr |
The ability to find closely correlated positions to NexturnBioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NexturnBioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NexturnBioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NexturnBioscience Co to buy it.
The correlation of NexturnBioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NexturnBioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NexturnBioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NexturnBioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in NexturnBioscience Stock
NexturnBioscience financial ratios help investors to determine whether NexturnBioscience Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NexturnBioscience with respect to the benefits of owning NexturnBioscience security.